HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
Open Access
- 28 September 2019
- journal article
- editorial
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 7 (3), 1-2
- https://doi.org/10.14218/jcth.2019.00047
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Chronic Hepatitis B InfectionJAMA, 2018
- Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling studyThe Lancet Gastroenterology & Hepatology, 2018
- Novel targets for hepatitis B virus therapyLiver International, 2017
- Present and future therapies of hepatitis B: From discovery to cureJournal of Hepatology, 2015
- HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis BGut, 2015
- Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic InfectionPLOS ONE, 2014
- AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active ReplicationPLOS ONE, 2014
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into HepatocytesGastroenterology, 2014
- IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosomeJCI Insight, 2012
- Serum Hepatitis B Surface Antigen Quantitation Can Reflect Hepatitis B Virus in the Liver and Predict Treatment ResponseClinical Gastroenterology and Hepatology, 2007